pubmed-article:3737126 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3737126 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:3737126 | lifeskim:mentions | umls-concept:C0339573 | lld:lifeskim |
pubmed-article:3737126 | lifeskim:mentions | umls-concept:C0395482 | lld:lifeskim |
pubmed-article:3737126 | lifeskim:mentions | umls-concept:C0392247 | lld:lifeskim |
pubmed-article:3737126 | lifeskim:mentions | umls-concept:C1609177 | lld:lifeskim |
pubmed-article:3737126 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:3737126 | pubmed:dateCreated | 1986-9-25 | lld:pubmed |
pubmed-article:3737126 | pubmed:abstractText | The effect of argon laser trabeculoplasty (ALT) on lowering intraocular pressure (IOP) was studied retrospectively in 68 black patients and 42 white patients with uncontrolled primary open-angle glaucoma on maximally tolerated medical therapy. Patients with the diagnosis of pigmentary or pseudoexfoliation glaucoma and those having previous intraocular or laser surgery were excluded. While the mean age of the black patients (66.9 years) was lower than the white patients (72.2 years), the prelaser IOP was similar between the two groups: 26.2 mmHg for the black patients and 25.5 mmHg for the white patients. The mean IOP one year (18.4 mmHg for black patients and 18.4 mmHg for white patients) and two years (19.5 mmHg and 20.3 mmHg, respectively) after ALT was the same between the two groups of patients. A similar percentage of black (85%) and white (83%) patients showed more than a 15% decrease in IOP from their prelaser values one year after treatment. The IOP lowering effect of ALT decreased during the second post-operative year; but the diminished response was identical in patients of both races, with 71% of patients of both groups still showing greater than 15% reduction from their pre-laser IOP. We conclude that ALT is equally effective in lowering IOP for black and white patients with medically uncontrolled primary open-angle glaucoma. | lld:pubmed |
pubmed-article:3737126 | pubmed:language | eng | lld:pubmed |
pubmed-article:3737126 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3737126 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:3737126 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3737126 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3737126 | pubmed:month | Jun | lld:pubmed |
pubmed-article:3737126 | pubmed:issn | 0161-6420 | lld:pubmed |
pubmed-article:3737126 | pubmed:author | pubmed-author:StoneR ARA | lld:pubmed |
pubmed-article:3737126 | pubmed:author | pubmed-author:KrupinTT | lld:pubmed |
pubmed-article:3737126 | pubmed:author | pubmed-author:KeatesE UEU | lld:pubmed |
pubmed-article:3737126 | pubmed:author | pubmed-author:WernerE BEB | lld:pubmed |
pubmed-article:3737126 | pubmed:author | pubmed-author:KurataF KFK | lld:pubmed |
pubmed-article:3737126 | pubmed:author | pubmed-author:BishopK IKI | lld:pubmed |
pubmed-article:3737126 | pubmed:author | pubmed-author:KozartD MDM | lld:pubmed |
pubmed-article:3737126 | pubmed:author | pubmed-author:PatkinRR | lld:pubmed |
pubmed-article:3737126 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3737126 | pubmed:volume | 93 | lld:pubmed |
pubmed-article:3737126 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3737126 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3737126 | pubmed:pagination | 811-6 | lld:pubmed |
pubmed-article:3737126 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:3737126 | pubmed:meshHeading | pubmed-meshheading:3737126-... | lld:pubmed |
pubmed-article:3737126 | pubmed:meshHeading | pubmed-meshheading:3737126-... | lld:pubmed |
pubmed-article:3737126 | pubmed:meshHeading | pubmed-meshheading:3737126-... | lld:pubmed |
pubmed-article:3737126 | pubmed:meshHeading | pubmed-meshheading:3737126-... | lld:pubmed |
pubmed-article:3737126 | pubmed:meshHeading | pubmed-meshheading:3737126-... | lld:pubmed |
pubmed-article:3737126 | pubmed:meshHeading | pubmed-meshheading:3737126-... | lld:pubmed |
pubmed-article:3737126 | pubmed:meshHeading | pubmed-meshheading:3737126-... | lld:pubmed |
pubmed-article:3737126 | pubmed:meshHeading | pubmed-meshheading:3737126-... | lld:pubmed |
pubmed-article:3737126 | pubmed:meshHeading | pubmed-meshheading:3737126-... | lld:pubmed |
pubmed-article:3737126 | pubmed:meshHeading | pubmed-meshheading:3737126-... | lld:pubmed |
pubmed-article:3737126 | pubmed:meshHeading | pubmed-meshheading:3737126-... | lld:pubmed |
pubmed-article:3737126 | pubmed:meshHeading | pubmed-meshheading:3737126-... | lld:pubmed |
pubmed-article:3737126 | pubmed:meshHeading | pubmed-meshheading:3737126-... | lld:pubmed |
pubmed-article:3737126 | pubmed:meshHeading | pubmed-meshheading:3737126-... | lld:pubmed |
pubmed-article:3737126 | pubmed:meshHeading | pubmed-meshheading:3737126-... | lld:pubmed |
pubmed-article:3737126 | pubmed:year | 1986 | lld:pubmed |
pubmed-article:3737126 | pubmed:articleTitle | Argon laser trabeculoplasty in black and white patients with primary open-angle glaucoma. | lld:pubmed |
pubmed-article:3737126 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3737126 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:3737126 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |